Development of Therapeutics for Children-A Tricky Balancing Act

Affiliations

Comment

Michael Cohen-Wolkowiez et al. JAMA Pediatr. 2019.

. 2019 Jan 1;173(1):18-19.

doi: 10.1001/jamapediatrics.2018.4026.

No abstract available

Comment on

Completion Rate and Reporting of Mandatory Pediatric Postmarketing Studies Under the US Pediatric Research Equity Act.
Hwang TJ, Orenstein L, Kesselheim AS, Bourgeois FT. Hwang TJ, et al. JAMA Pediatr. 2019 Jan 1;173(1):68-74. doi: 10.1001/jamapediatrics.2018.3416. JAMA Pediatr. 2019. PMID: 30452498 Free PMC article.
Duration of Pediatric Clinical Trials Submitted to the US Food and Drug Administration.
Zimmerman KO, Smith PB, McMahon AW, Temeck J, Avant D, Murphy D, McCune S. Zimmerman KO, et al. JAMA Pediatr. 2019 Jan 1;173(1):60-67. doi: 10.1001/jamapediatrics.2018.3227. JAMA Pediatr. 2019. PMID: 30452504 Free PMC article. Review.